Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $130K invested in Sonnet BioTherapeutics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
9
Holders Change
+7
Holders Change %
+350%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $58K | 39,647 | +39,647 | New |
|
2
Citadel Advisors
Miami,
Florida
| $35.1K | 24,013 | +24,013 | New |
|
3
Two Sigma Investments
New York
| $28K | 19,203 | +19,203 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $8.91K | 6,100 | +5,722 | +1,514% |
|
5
BlackRock
New York
| $95 | 65 | – | – |
|
|
CWA
6
Carolina Wealth Advisors
Myrtle Beach,
South Carolina
| $47 | 32 | +32 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $7 | 5 | +5 | New |
|
8
UBS Group
Zurich,
Switzerland
| $4 | 3 | +3 | New |
|
9
Citigroup
New York
| $3 | 2 | +2 | New |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
PWMG
11
Private Wealth Management Group
Princeton,
New Jersey
| – | – | – | – |
|